glp-1 and bowel obstruction can glp 1 cause Your guide to side effects kentucky semaglutide gi obstruction law

Food and Drug Administration (FDA) to treat individuals with type 2 diabetes mellitus and obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) with at least one other weight-related medical condition

Patients with diabetes who are initiating GLP-1 RAsespecially those with elevated baseline hemoglobin A1c or anticipated rapid reductionmay benefit from being monitored more closely than suggested by the American Academy of Ophthalmology preferred practice pattern, which is based on the current level of retinopathy

The concentration is similar, typically 2 mg per mL

This applies even more to populations at higher-relative risk such as the elderly, those with pre-existing PDR or prolonged DM, individuals on multiple medications for their diabetes, and those who experience rapid reductions in either body weight or blood glucose